Sporadic amyotrophic lateral sclerosis: A hypothesis of persistent (non‐lytic) enteroviral infection

References

• de la Torre JC, Oldstone MBA. Anatomy of viral persis- tence: mechanisms of persistence and associated disease. Adv Virus Research. 1996;46:311–43.
   Google Scholar
• Salazar-Gureso EF, Roos RP. Amyotrophic lateral sclerosis and viruses. Clin Neurosci. 1995;3:360–7.
   Google Scholar
• Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. NEJM. 2001;344:1688–700.
   PubMed Web of Science ®Google Scholar
• Viola M, Myers J, Gramm K, Gibbs JC Jr, Roos RP. Failure to detect poliovirus genetic information in amyotrophic lateral sclerosis. Ann Neurol. 1979;5:402–3.
   Google Scholar
• Cremer N, Oshiro L, Norris F. Cultures of tissues from patients with amyotrophic lateral sclerosis. Arch Neurol. 1973;29:331–3.
   Google Scholar
• Muller WK, Schaltenbrtand G. Attempts to reproduce amyotrophic lateral sclerosis in laboratory animals by inoculation of Schu virus isolated from patient with apparent amyotrophic lateral sclerosis. J Neurol. 1979;220:1–19.
   PubMed Web of Science ®Google Scholar
• Norris FJ Jr. Current status of the search for virus in amyotrophic lateral sclerosis. Neuro Neuro Psychiatr. 1977;18(Suppl. 2–3): 443–54.
   Google Scholar
• Weiner LP, Stohlman SA, Davis R. Attempts to demonstrate virus in amyotrophic lateral sclerosis. Neurology. 1980;30:1319–22.
   Google Scholar
• Gibbs CJ, Gajdusek DC. An update on long-term in vivo and in vitro studies designed to identify a virus as the cause of amyotrophic lateral sclerosis, Parkinsonism dementia and Parkinson’s disease. In: Rowland LP, editor. Human Motor Neuron Diseases. New York: Raven Press; 1982. pp 343–53.
   Google Scholar
• Fallis RJ, Weiner LP. Further studies in search of a virus in amyotrophic lateral sclerosis. In: Rowland LP, editor. Human Motor Neuron Diseases. New York: Raven Press; 1982. pp 355–61.
   Google Scholar
• Kennedy PGE. On the possible role of viruses in the eetiology of motor neuron disease: a review. J Royal Soc Med. 1990;83:784–7.
   Google Scholar
• Jubelt B. Viruses and motor neuron diseases. Adv Neurol. 1991;56:463–72.
   PubMedGoogle Scholar
• Fraser H, Behan W, Chree A, Crossland G, Behan P. Mouse inoculation studies reveal no transmissible agent in amyo- trophic lateral sclerosis. Brain Pathology. 1996;6:89–100.
   Google Scholar
• Miller J, Guntaka RM, Myers J. Amyotrophic lateral sclerosis. Search for poliovirus by nucleic acid hybridization. Neurology. 1980;30:884–6.
   Google Scholar
• Kohne DE, Gibbs CJ, White L, Tracy SM, Meinke W, Smith RA. Virus detection by nucleic acid hybridization examination of normal and ALS tissues for the presence of poliovirus. J Gen Virol. 1981;56:223–33.
   PubMedGoogle Scholar
• Brachic M, Smith RA, Gibbs CJ, Garruto RM, Tourtellotte WW, Cash E. Detection of picornavirus sequences in nervous tissue of amyotrophic lateral sclerosis and control patients. Ann Neurol. 1985;18:337–43.
   Google Scholar
• Love S. The search for a transmissible agent in ALS. Brain Pathol. 1996;6:99–100.
   PubMed Web of Science ®Google Scholar
• Muir P, Nicholson F, Spencer GT, Ajetunmobi JF, Starkey WG, Khan M, et al. Enterovirus infection of the central nervous system of humans: lack of association with chronic neurological disease. J Gen Virol. 1996;77:1469–76.
   Google Scholar
• Muir P, van Loon AM. Enterovirus infections of the central nervous system. Intervirology. 1997;40:153–66.
   PubMed Web of Science ®Google Scholar
• Harber J, Bernhardt G, Lu H, Sgro JY, Wimmer E. Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor. Virology. 1995;214:559–70.
   PubMed Web of Science ®Google Scholar
• Bodian D. Histopathologic basis of clinical findings in poliomyelitis. Am J Med. 1949;6:563–78.
   PubMed Web of Science ®Google Scholar
• Sabin AB, Ward R. The natural history of human poliomyelitis. I. Distribution of virus in nervous and non- nervous tissues. J Exp Med. 1941;73:771–93.
   Google Scholar
• Johnson RT. Selective vulnerability of neural cells to viral infections. In: Rowland LP, editor. Human Motor Neuron Diseases. New York: Raven Press; 1982. pp 331–7.
   Google Scholar
• Salazar-Grueso EF, Cashmann NR, Maselli R, Roos RP. Upper motor neuron findings in patients with antecedent poliomyelitis. Neurology. 1987;37(Suppl1): 215.
   Google Scholar
• Melchers W, de Villser M, Jongen P, van Loon A, Nibbeling R, Oostvogel P, et al. The postpolio syndrome: no evidence for poliovirus persistence. Ann Neurol. 1992;32:728–32.
   PubMed Web of Science ®Google Scholar
• Dalakas MC, Illa I. Post-polio syndrome: concepts in clinical diagnosis, pathogenesis and etiology. Adv Neurol. 1991;56:495–511.
   Google Scholar
• Giraud P, Kopp N, Lina B, Chazot G. La scle´rose late´rale amotrophique: implication des ente´rovirus? Rev Neurol. (Paris). 2000;156:352–6.
   Google Scholar
• Harter DH. Viruses other than poliovirus in human amyotrophic lateral sclerosis. In: Rowland LP, editor. Human Motor Neuron Diseases. New York: Raven Press; 1982. pp 339–42.
   Google Scholar
• Westarp ME, Foring B, Rasmussen H, Schraff S, Mertens T, Kornhuber HH. Human spuma retrovirus antibodies in amyotrophic lateral sclerosis. Neuro, Psych, Brain Res. 1992;1:1–4.
   Google Scholar
• Westarp ME, Ferrante P, Perron H, Bartmann P, Kornhuber HH. Sporadic ALS/MND: a global neuro- deneration with retroviral involvement? J Neurol Sci. 1995;129(Suppl): 145–7.
   Google Scholar
• Rosener M, Hahn H, Kranz M, Heeney J, Rethwilm A. Absence of serological evidence for foamy virus infection in patients with amyotrophic lateral sclerosis. J Med Virol. 1996;48:222–6.
   Google Scholar
• Andrews WD, Tuke PW, Al-Chalabi A, Gaudin P, Ijaz S, Parton MJ, Garson JA. Detection of reverse transcriptase activity in the serum of patients with motor neuron disease. J Med Virol. 2000;61:527–32.
   PubMed Web of Science ®Google Scholar
• Moulignier A, Moulonguet A, Pialoux G, Rozenbaum W. Reversible ALS-like disorder in HIV infection. Neurology. 2001;57:995–1001.
   PubMed Web of Science ®Google Scholar
• MacGowan DJ, Scelsa SN, Waldron M. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology. 2001;57:1094–7.
   PubMed Web of Science ®Google Scholar
• Jubelt B, Berger JR. Does viral disease underlie ALS? Lessons from the AIDS pandemic. Neurology. 2001;57:945–6.
   PubMed Web of Science ®Google Scholar
• Cermelli C, Vinceti M, Beretti F, Pietrini V, Nacci G, Pietrosemoli P, et al. Risk of sporadic amyotrophic lateral sclerosis associated with seropositivity for herpesviruses and echovirus-7. Eur J Epidemiol. 2003;18:123–7.
   Google Scholar
• Andrews WE, Al-Chalabi A, Garson JA. Lack of evidence for HTLV tax-rex DNA in motor neuron disease. J Neurol Sci. 1997;153:86–90.
   Google Scholar
• Sola P, Bedin R, Casoni F, Barozzi P, Mandrioli J, Merelli E. New insights into the viral theory of amyotrophic lateral sclerosis: study on the possible role of Kaposi’s sarcoma- associated virus/human herpesvirus 8. Eur Neurol. 2002;47:108–12.
   Google Scholar
• Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase-catalysed chain rection. Methods Enzymol. 1987;155:335–50.
   PubMed Web of Science ®Google Scholar
• Saiki R, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988;239:487–91.
   PubMed Web of Science ®Google Scholar
• Hyypia T, Auvinen P, Maaronen M. Polymerase chain reaction for human picornaviruses. J Gen Virol. 1989;70:3261–8.
   PubMed Web of Science ®Google Scholar
• Rotbart HA. Enzymatic RNA amplification of the enter- oviruses. J Clin Microbiol. 1990;28:438–42.
   PubMed Web of Science ®Google Scholar
• Chapman NM, Tracy S, Gauntt CJ, Fortmueller U. Molecular detection and identification of enteroviruses using enzymatic amplification and nucleic acid hybridization. J Clin Microbiol. 1990;28:843–50.
   PubMed Web of Science ®Google Scholar
• Woodall CJ, Riding MH, Graham DI, Clements GB. Sequences specific for enterovirus detected in spinal cord from patients with motor neuron disease. Br Med J. 1994;308:1541–3.
   PubMedGoogle Scholar
• Berger MM, Kopp N, Vital C, Redl B, Aymard M, Lina B. Detection and cellular localization of enterovirus RNA sequences in spinal cord of ALS patients. Neurology. 2000;54:20–25.
   PubMed Web of Science ®Google Scholar
• Giraud P, Beaulieux F, Ono S, Shimizu N, Chazot G, Lina B. Detection of enteroviral sequences from frozen spinal cord samples of Japanese ALS patients. Neurology. 2001;56:1777–8.
   PubMed Web of Science ®Google Scholar
• Swanson NR, Fox SA, Mastaglia FI. Search for persistent infection with poliovirus or other enteroviruses in amyo- trophic lateral sclerosis. Neuromusc Disord. 1995;5:457–65.
   Google Scholar
• Walker MP, Schlaberg R, Hays AP, Bowser R, Lipkin WI. Absence of echovirus sequences in brain and spinal cord of amyotrophic lateral sclerosis patients. Ann Neurol. 2001;49:249–53.
   PubMedGoogle Scholar
• Nix WA, Berger MM, Oberste MS, Brooks BR, McKenna- Yasek DM, Brown RH Jr, et al. Failure to detect enterovirus in the spinal cord of ALS patients using a sensitive RT-PCR method. Neurology. 2004;62:1372–7.
   Google Scholar
• Oldstone MBA. Viruses can cause disease in the absence of morphological evidence of cell injury: implication for uncovering new diseases in the future. J Inf Diseases. 1989;159:384–9.
   Google Scholar
• Oldstone MB. Viral persistence: mechanisms and conse- quences. Current Opinion in Microbiolgy. 1998;1:436–41.
   Google Scholar
• Ahmed R, Morrison LA, Knipe DM. Viral persistence. In: Nathanson N, et al., eds, Viral Pathogenesis. Philadelphia: Lippincott-Raven Publishers; 1997. Chapter 9.
   Google Scholar
• Lipton HL, Gilden DH. Viral diseases of the nervous system: persistent infections. In: Nathanson N, et al., eds, Viral Pathogenesis. Philadelphia: Lippincott-Raven Publishers; 1997. Chapter 36, 1997.
   Google Scholar
• Ter Meulen V, Carter MJ, Wege H, Watanabe R. Mechanisms and consequences of virus persistence in the human nervous system. Ann NY Acad Sci. 1984;436:86–97.
   Google Scholar
• Ahmed R, Chen ISY, editors, Persistent Viral Infections. Chichester: John Wiley & Sons; 1999.
   Google Scholar
• Alcami A, Koszinowski UH. Viral mechanisms of immune evasion. Trends Microbiol. 2000;8:410–8.
   PubMed Web of Science ®Google Scholar
• Mahalingam S, Meanger J, Foster P, Lidbury BA. The viral manipulation of the host cellular and immune environments to enhance propagation and survival: a focus on RNA viruses. J Leukocyte Biology. 2002;72:429–39.
   PubMedGoogle Scholar
• Vossen MTM, Westerhout EM, Soo¨ derbert-Naucle´r C, Wiertz EJ. Viral immune evasion: a masterpiece of evolution. Immunogenetics. 2002;54:527–42.
   PubMed Web of Science ®Google Scholar
• Frisk G. Mechanisms of chronic enteroviral persistence in tissue. Current Opin Infect Dis. 2001;14:251–6.
   Google Scholar
• McKinney RE, Katz SL, Wilfert CM. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infects Dis. 1987;9:334–56.
   PubMedGoogle Scholar
• Zhang S, Racaneillo VR. Peristent echovirus infection of mouse cells expressing the viral receptor VLA-2. Virology. 1997;235:293–301.
   Google Scholar
• Pavio N, Buc-Caron MH, Colbere-Garpin F. Persistent poliovirus infection of human fetal brain cells. J Virol. 1996;70:6395–401.
   Google Scholar
• Carp RI. Persistent infection of human lymphoid cells with poliovirus and development of temperature sensitive mutants. Intervirology. 1981;15:49–56.
   Google Scholar
• Lloyd RE, Bovee M. Persistent infection of human erythroblastoid cells by poliovirus. Virology. 1993;194:200–9.
   Google Scholar
• Colbere-Garapin F, Christodoulou C, Crainic R, Pelletier I. Persistent poliovirus infection of human neuroblastoma cells. Proc Natl Acad Sci. USA. 1989;86:7590–4.
   Google Scholar
• Borzakian S, Couderc T, Barbier Y, Attal G, Pelletier I, Colbere-Garapin F. Persistent poliovirus infection: estab- lishment and maintenance involve distinct mechanisms. Virology. 1992;186:398–408.
   PubMed Web of Science ®Google Scholar
• Pelletier I, Duncan G, Pavio, et al. Molecular mechanisms of poliovirus persistence: key role of capsid determinants during the establishment phase. Cell Mol Life Sci. 1998;54:1385–1402.
   Google Scholar
• Blondel B, Duncan G, Couderc T, et al. Molecular aspects of poliovirus biology with a special focus on the interactions with nerve cells. J NeuroVirol. 1998;4:1–26.
   PubMed Web of Science ®Google Scholar
• Morrison ME, He YJ, Wien MW, Hogle JM, Racaniello VR. Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication. J Virol. 1994;68:2578–88.
   PubMedGoogle Scholar
• Colbere-Garapin F, Jacques S, Drillet AS, Pavio N, Couderc T, Blondel B, et al. Poliovirus persistence in human cells in vitro. Dev Biol. (Basel). 2001;105:99–104.
   Google Scholar
• Destombes J, Couderc T, Thiesson D, Girard S, Wilt SG, Blondel B. Persistent poliovirus infection in mouse motor neurons. J Virol. 1997;71:1621–8.
   PubMedGoogle Scholar
• Leparc-Goffart I, Julien J, Fuchs F, Janatova I, Aymard M, Kopecka H. Evidence for the presence of poliovirus genomic sequences in the CSF of patients with post-polio syndrome. J Clin Microbiol. 1996;34:2023–6.
   Google Scholar
• See DM, Kean KM, Kopecka H. Analysis of the sequence of a poliovirus type 2-like defective interfering virus from the cerebrospinal fluid of a patient with post-polio syn- drome. Abstract 5th Congres de la Societe Franaise de Microbiologie, Lille, France, April 28 1998.
   Google Scholar
• Julien J, Leparc-Goffart I, Lina B, Fuchs F, Foray S, Janatova I, et al. Post-polio syndrome: poliovirus persistence is involved in the pathogenesis. J Neurol. 1999;246:472–6.
   Google Scholar
• Leon-Monzon ME, Dalakas MC. Detection of poliovirus antibodies and poliovirus genome in patients with the post- polio syndrome. Ann NY Acad Sci. 1995;753:208–18.
   PubMedGoogle Scholar
• Sharief MK, Hentges R, Ciardi M. Intrathecal immune response in patients with the post-polio syndrome. N Engl J Med. 1991;325:749–55.
   Google Scholar
• Galbraith DN, Nairn C, Clements GB. Evidence for enteoviral persistence in humans. J Gen Virology. 1997;78:307–12.
   PubMed Web of Science ®Google Scholar
• Kristensson K, Norrby E. Persistence of RNA viruses in the central nervous system. Ann Rev Microbiol. 1986;40:159–84.
   Google Scholar
• Johnson RT. Chronic inflammatory and demyelinating diseases. In: Viral Infections of the Nervous System (2nd edn). Philadelphia: Lippincott-Raven Press; 1998. Chapter 10.
   Google Scholar
• Coles A, Scolding N. Immune responses and the nervous system. In: Scolding N, editor. Immunological and Inflam- matory Disorders of the Central Nervous System. Oxford: Butterworth Heinemannn; 1999. Chapter 1. pp 1–20.
   Google Scholar
• Jolly E, Mucke L, Oldstone M. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science. 1991;253:1283–5.
   Google Scholar
• Perlman S, Wu GF. Selection of and evasion from cytotoxic T-cell responses in the central nervous system. In: Buchmeier MJ, Campbell MJ, editors. Neurovirology: Viruses and the Brain. San Diego: Academic Press; 2001. pp 219–42.
   Google Scholar
• McGeer PL, McGeer EG. Inflammatory processes in amytrophic lateral sclerosis. Muscle Nerve. 2002;26:459–70.
   PubMed Web of Science ®Google Scholar
• McGreer PL, Itagaki S, McGreer EG. Expression of histocompatibility glycoprotein HLA-DR in neurological disease. Acta Neuropathol. 1988;76:550–7.
   Google Scholar
• Troost D, van den Oord JJ, de Jong JM, Swaab DF. Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis. Clin Neuropathology. 1989;8:289–94.
   PubMed Web of Science ®Google Scholar
• Engelhardt JI, Appel SH. IgG reactivity in the spinal cord and motor neurons in amyotrophic lateral sclerosis. Arch Neurol. 1990;47:1210–6.
   PubMed Web of Science ®Google Scholar
• Lampson LA, Kushner PD, Sobel RA. Major histocompat- ibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis. Ann Neurol. 1990;28:365–72.
   PubMed Web of Science ®Google Scholar
• Troost D, Van den Oord JJ, De Jong JMBV. Immuno- histochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis. Neuropath Appl Neurobiol. 1990;16:401–10.
   PubMed Web of Science ®Google Scholar
• Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Path. 1992;140:691–707.
   PubMed Web of Science ®Google Scholar
• Engelhardt JI, Tajti J, Appel SH. Lymphocytic infiltrate in the spinal cord in amyotrophic lateral sclerosis. Arch Neurol. 1993;50:30–6.
   PubMedGoogle Scholar
• Roulston A, Marcellus RC, Brapton PE. Viruses and apoptosis. Annu Rev Microbiol. 1999;53:577–628.
   PubMed Web of Science ®Google Scholar
• O’Brien V. Viruses and apoptosis. J Gen Virol. 1998;79:1833–45.
   PubMed Web of Science ®Google Scholar
• Hardwick JM. Viral-induced apoptosis. Adv Pharmacol. 1997;41:295–336.
   PubMedGoogle Scholar
• Young LS, Dawson C, Eliopsulos AG. Viruses and apoptosis. Br Med Bull. 1997;53:509–21.
   PubMed Web of Science ®Google Scholar
• Shen Y, Shenk TE. Viruses and apoptosis. Curr Opin Genet Dev. 1995;5:105–11.
   PubMedGoogle Scholar
• Allsopp TE, Fazakerley JK. Altruistic cell suicide and the specialized case of the virus-infected nervous system. Trends Neurosci. 2000;23:284–90.
   PubMedGoogle Scholar
• Thomson BJ. Viruses and apoptosis. Int J Exp Pathol. 2001;82:65–76.
   PubMed Web of Science ®Google Scholar
• Barber GN. Host defense, viruses and apoptosis. Cell Death Differ. 2001;8:113–26.
   PubMed Web of Science ®Google Scholar
• Fazakerley JK, Allsopp TE. Programmed cell death in virus infections of the nervous system. Curr Top Microbiol Immunol. 2001;253:95–119.
   PubMedGoogle Scholar
• Ubol S, Tucker PC, Griffin DE, Hardwick JM. Neurovirulent strains of alphavirus induce apoptosis in bcl-2-expressing cells: role of a single amino acid change in the E2 glycoprotein. Proc Natl Acad Sci. USA. 1994;91:5202–6.
   PubMed Web of Science ®Google Scholar
• Levine B, Huang Q, Isaacs JT, Reed JC, Griffin DE, Hardwick JM. Conversion of lytic to persistent alphavirus infection by bcl-2 cellular oncogene. Nature. 1993;361:739–42.
   PubMed Web of Science ®Google Scholar
• Tolskaya EA, Romanova LI, Kolesnikova MS, Ivannikova TA, Smirnova EA, Raikhlin NT, et al. Apoptosis-inducing and apoptosis-preventing functions of poliovirus. J Virol. 1995;69:1181–9.
   PubMed Web of Science ®Google Scholar
• Agol VI, Belov GA, Bienz K, Egger D, Kolesnikova MS, Raikhlin NT, et al. Two types of death of poliovirus-infected cells: caspase involvement in the apoptosis but not cyto- pathic effect. Virology. 1998;252:343–53.
   Google Scholar
• Girard S, Couderc T, Destombes J, Thiesson D, Delpeyroux F, Blondel B. Poliovirus induces apoptosis in the mouse central nervous system. J Virol. 1999;73:6066–72.
   PubMedGoogle Scholar
• Barco A, Feduchi E, Carrssco L. Poliovirus protease 3Cpro kills cells by apoptosis. Virology. 2000;266:352–60.
   PubMedGoogle Scholar
• Goldstaub D, Gradi A, Bercovitch Z, Grosmann Z, Nophar Y, Luria S, et al. Poliovirus 2A protease induces apoptotic cell death. Mol Cell Biol. 2000;20:1271–7.
   PubMedGoogle Scholar
• Blaschke AJ, Weiner JA, Chun J. Programmed cell death is a universal feature of embryonic and postnatal neuroproli- ferative regions throughout the central nervous system. J Comp Neurol. 1998;396:39–50.
   PubMed Web of Science ®Google Scholar
• Johnson EM, Deckwerth TL. Molecular mechanisms of developmental neuronal death. Annu Rev Neurosci. 1993;16:31–46.
   PubMed Web of Science ®Google Scholar
• Yuan J, Yankner BA. Apoptosis in the nervous system. Nature. 2000;407:802–9.
   PubMed Web of Science ®Google Scholar
• Burek MJ, Oppenheim RW. Cellular interactions that regulate programmed cell death in the developing vertebrate nervous system. In: Koliatsos VE, Ratan RR, editors. Cell death and diseases of the nervous system. New Jersey: Humana Press Inc; 1999. pp 145–179.
   Google Scholar
• Yoshiyama Y, Yamada T, Asanuma K, Asahi T. Apoptosis related antigen, Ley and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol. 1994;88:207–11.
   PubMed Web of Science ®Google Scholar
• Troost D, Aten J, Morsink F, de Jong JM. Apoptosis in amyotrophic lateral sclerosis in not restricted to motor neurons. Bcl-2 expression is increased in unaffected post- central gyrus. Neuropath Appl Neurobiol. 1995;21:498–504.
   Google Scholar
• Mu X, He J, Anderson DW, Trojanowski JQ, Springer JE. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann Neurol. 1996;40:379–86.
   PubMed Web of Science ®Google Scholar
• Martin LJ. Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J Neuropathol Exp Neurol. 1999;58:459–71.
   PubMed Web of Science ®Google Scholar
• Ekegren T, Grundstrom E, Lindholm D, Aquilonius SM. Up-regulation of Bax protein and increased DNA degrada- tion in ALS spinal cord motor neurons. Acta Neurol Scand. 1999;1000:317–21.
   Google Scholar
• Sathasivam S, Ince PG, Shaw PJ. Apoptosis in amyotrophic lateral sclerosis: a review of the evidence. Neuropathol Appl Neurobiol. 2001;27:257–74.
   PubMed Web of Science ®Google Scholar
• Gue´gan C, Przedborski S. Programmed cell death in amyo- trophic lateral sclerosis. J Clin Invest. 2003;111:153–61.
   PubMed Web of Science ®Google Scholar
• Griffin DE, Hardwick JM. Perspective: virus infections and the death of neurons. Trends Microbiol. 1999;7:155–60.
   PubMedGoogle Scholar
• Everett H, McFadden G. Apoptosis: an innate immune response to virus infection. Trends Microbiol. 1999;7:160–5.
   PubMed Web of Science ®Google Scholar
• Friedlander RM. Apoptosis and caspases in neurodegenera- tive diseases. NEJM. 2003;348:1365–75.
   PubMed Web of Science ®Google Scholar
• Gosztonyi G, Koprowski H. The concept of neurotropism and selective vulnerability (‘pathoclisis’) in virus infections of the nervous system: a historical overview. Curr Top Microbiol Immunol. 2001;253:1–13.
   Google Scholar
• Evans DJ, Almond JW. Cell receptors for picornaviruses as determinants of cell tropism and pathogenesis. Trends Microbiol. 1998;6:198–202.
   Google Scholar
• Rossmann MG, Bella J, Kolatkar PR, He Y, Wimmer E, Kuhn RJ, et al. Cell recognition and entry by rhinoviruses and enteroviruses. Virology. 2000;269:239–47.
   PubMedGoogle Scholar
• Rossmann MG, He Y, Kuhn RJ. Picornavirus-receptor interactions. Trends Microbiol. 2002;10:324–31.
   PubMed Web of Science ®Google Scholar
• Ohka S, Nomoto A. Recent insights into poliovirus pathogenesis. Trends Microbiology. 2001;9:501–6.
   PubMed Web of Science ®Google Scholar
• Nomoto A, Koike S, Aoki HJ. Tissue tropism and species specificity of poliovirus infection. Trends Microbiology. 1994;2:47–51.
   Google Scholar
• Rossmann MG, Bella J, Kolatkar R, He Y, Wimmer E, Kuhn RJ, et al. Cell recognition and entry by rhinoviruses and enteroviruses. Virology. 2000;269:239–47.
   PubMedGoogle Scholar
• Belnap DM, McDermott BM Jr, Filman DJ, Cheng N, Trus BL, Zuccola HJ, et al. Three-dimensional structure of poliovirus receptor bound to poliovirus. Proc Natl Acad Sci. 2000;97:73–8.
   Google Scholar
• Gromeier M, Lu HH, Bernhardt G, Harber JJ, Bibb JA, Wimmer E. The human poliovirus receptor: receptor-virus interaction and parameters of disease specificity. Ann NY Acad Sci. 1995;753:19–36.
   Google Scholar
• Bernhardt G, Bibb JA, Bradley J, Wimmer E. Molecular characterization of the cellular receptor for poliovirus. Virology. 1994;199:105–13.
   Google Scholar
• Racaneillo VR. The poliovirus receptor: a hook or an unzipper? Structure. 1996;4:769–73.
   Google Scholar
• Solecki D, Gromeier M, Harber J, Bernhardt G, Wimmer E. Poliovirus and its cellular receptor: a molecular genetic dissection of a virus/receptor affinity interaction. J Mol Recogn. 1998;11:2–9.
   Google Scholar
• Racaniello VR. Early events in poliovirus infection: virus-receptor interactions. Poc Natl Acad Sci. USA. 1996;93:11378–81.
   Google Scholar
• Mendelsohn C, Johnson B, Lionetti KA, Nobis P, Wimmer E, Racaniello VR. Transformation of a human poliovirus receptor gene into mouse cells. Proc Natl Acad Sci. USA. 1986;83:7845–9.
   Google Scholar
• Rossman MG. The canyon hypothesis: hiding the host cell receptor attachment site on a viral surface from immune surveillance. J Biol Chem. 1989;264:14587–90.
   Google Scholar
• Wien MW, Chow M, Hogle JM. Poliovirus: new insights from an old paradigm. Structure. 1996;4:763–7.
   Google Scholar
• Belnap DM, McDermott BM, Filman DJ, Cheng N, Trus BL, Succola HJ, et al. Three-dimensional structure of poliovirus receptor bound to poliovirus. PNAS. 2000;97:73–8.
   PubMed Web of Science ®Google Scholar
• He Y, Bowman VD, Mueller S, Bator CM, Bella J, Peng X, et al. Interaction of the poliovirus receptor with poliovirus. PNAS. 2000;97:79–84.
   PubMed Web of Science ®Google Scholar
• Brown RH Jr, Johnson D, Ogonowski M, Weiner HL. Type 1 human poliovirus binds to human synaptosomes. Ann Neurol. 1987;21:64–70.
   Google Scholar
• Freistadt MF, Kaplan G, Racaniello VR. Heterogeneous expression of poliovirus receptor-related proteins in human cells and tissues. Mol Cell Biol. 1990;10:5700–6.
   PubMedGoogle Scholar
• Mendelsohn C, Wimmer E, Racaniello VR. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence and expression of a new member of the immu- noglobulin suerfamily. Cell. 1989;56:855–65.
   PubMed Web of Science ®Google Scholar
• Yang WX, Terasaki T, Shiroki K, Ohka S, Aoki J, Tanabe S, et al. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology. 1997;229:421–8.
   PubMed Web of Science ®Google Scholar
• Crotty S, Hix L, Sigal LJ, Andino R. Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age- dependent paralysis and a mucosal route of infection. J Gen Virol. 2002;83:1707–20.
   Google Scholar
• Ida-Hosonuma M, Iwasaki T, Taya C, Sato Y, Li J, Nagata N. Comparison of neuropathogenicity of poliovirus in two transgenic mouse strains expressing human poliovirus receptor with different distribution patterns. J Gen Virol. 2002;83:1095–105.
   Google Scholar
• Andino R, Boddeker N, Silvera D, Gamarnik AV. Intracellular determinants of picornavirus replication. Trends Microbiol. 1999;7:76–82.
   PubMedGoogle Scholar
• Jubelt B, Narayan O, Johnson RT. Pathogenesis of human poliovirus infection in mice. II. Age-dependency of paralysis. J Neuropathol Exp Neurol. 1980;39:149–59.
   Google Scholar
• Johnson RT. Pathogenesis of poliovirus infections. Ann NY Acad Sci. 1995;753:361–5.
   Google Scholar
• Johnson RT. Pathogenesis of central nervous system infections. In: Johnson RT, editor. Viral Infections of the Nervous System (2nd edn). Philadelphia: Lippincott-Raven; 1998. Chapter 3.
   Google Scholar
• Ren R, Racaniello VR. Poliovirus spreads from muscle to the central nervous system by neural pathways. J Infect Dis. 1992;166:747–52.
   PubMed Web of Science ®Google Scholar
• Illa I, Leon-Monzon M, Agboatwalla M, Dure-Samin A, Dalakas MC. Role of muscle in acute poliomyelitis infection. Ann NY Acad Sci. 1995;753:58–67.
   Google Scholar
• Gromeier M, Wimmer E. Mechanism of injury-provoked poliomyelitis. J Virol. 1998;72:5056–60.
   PubMedGoogle Scholar
• Bradford-Hill A, Knowelden J. Inoculation and poliomye- litis: a statistical investigation in England and Wales in 1949. Br Med J. 1950;2:1–6.
   Google Scholar
• McCloskey BP. The relationship of prophylactic inocula- tions to the onset of poliomyelitis. Lancet. 1950;2:659–63.
   Google Scholar
• Sutter RW, Patriarca PA, Suleiman AJ, Brogan S, Malankar PG, Cochi SL, et al. Attributable risk of DTP injection in provoking paralytic poliomyelitis during a large outbreak in Oman. J Infect Dis. 1992;165:444–9.
   Google Scholar
• Strebel PM, Ion-Nedelcu N, Baughman AL, Sutter RW, Cochi SL. Intramuscular injections within 30 days of immunization with oral poliovirus vaccine: a risk for vaccine-associated paralytic poliomyelitis. NEJM. 1995;332:500–6.
   PubMed Web of Science ®Google Scholar
• Nathanson N, Langmuir AD. The Cutter incident: polio- myelitis following formaldehyde inactivated poliovirus vac- cination in the United States during the spring of 1955. Am J Hyg. 1963;78:16–81.
   PubMed Web of Science ®Google Scholar
• Bodian D, Horstmann DH. Polioviruses. In: Horsfall FL, Tamm I, editors. Viral and rickettsial Infections of man. Philadelphia: Lippincott; 1965. pp 430–73.
   Google Scholar
• Bodian D, Howe HA. The rate of progression of poliomye- litis virus in nerves. Bull Johns Hopkins Hosp. 1941;69:79–85.
   Google Scholar
• Samuel BU, Ponnuraj E, Rajasingh J, John TJ. Experimental poliomyelitis in bonnet monkey: clinical features, virology and pathology. In: Brown F, Lewis BP, eds. Poliovirus attenuation: molecular mechanisms and practical aspects. Dev Biol Stand. 1993;78:71–8.
   Google Scholar
• Leon-Monzon ME, Illa I, Dalakas MC. Expression of poliovirus receptor in human spinal cord and muscle. Ann NY Acad Sci. 1995;753:48–57.
   Google Scholar
• Ohka S, Yang WX, Terada E, Iwasaki K, Nomoto A. Retrograde transport of intact poliovirus through the axon via the fast transport system. Virol. 1998;250:67–75.
   PubMed Web of Science ®Google Scholar
• Ponnuraj EM, John TJ, Levin MJ, Simoes EA. Cell-to-cell spread of poliovirus in the spinal cord of bonnet monkeys. J Gen Virol. 1998;79:2393–403.
   Google Scholar
• Chou SM, Norris FH. Amyotrophic lateral sclerosis: lower motor neuron disease spreading to upper motor neuron disease. Muscle & Nerve. 1993;16:864–9.
   PubMed Web of Science ®Google Scholar
• Sigurdsson B. Observations on three slow infections of sheep: maedi, paratuberculosis, rida, a slow encephalitis of sheep with general remarks on infections which develop slowly, and some of their special characteristics. Br Vet J. 1954;110:255–70.
   Google Scholar
• O’Connell J, Albin R, Blum D, Grint P, Schwartz J. Development of antiviral agents for picornavirus infections. In: Rotbart HA, editor. Human Enteroviral Infections. Washington DC: American Society for Microbiology; 1995. Chapter 18.
   Google Scholar
• Smith TJ, Kremer MJ, Luo M, Vriend G, Arnold E, Kamer G, et al. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science. 1986;233:1286–93.
   PubMed Web of Science ®Google Scholar
• Rossmann MG. The structure of antiviral agents that inhibit uncoating when complexed with viral capsids. Antiviral Res. 1989;11:3–14.
   Google Scholar
• Zhang A, Nanni RG, Li T, Arnold GF, Oren DA, Jacobo- Molina A, et al. Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14. J Mol Biol. 1993;230:857–67.
   Google Scholar
• McKinley MA, Fever DC, Rosen MG. Treatment of the picornavirus common cold by inhibitors of viral uncoating and attachment. Annu Rev Microbiol. 1992;46:635–45.
   Google Scholar
• Oliveira MA, Zhao R, Lee WM, Kremer MJ, Minor I, Rueckert RR, et al. The structure of human rhinovirus 16. Structure. 1993;1:51–68.
   PubMed Web of Science ®Google Scholar
• Lewis JK, Bothner B, Smith TJ, Siuzdak G. Antiviral agent blocks breathing of the common cold virus. Proc Natal Acad Sci. USA. 1998;95:6774–8.
   PubMed Web of Science ®Google Scholar
• Wang W, Lee WM, Mosser AG, Rueckert RR. WIN 52035- dependent human rhinovirus 16: assembly deficiency caused by mutations near the canyon surface. J Virol. 1998;72:1210–8.
   Google Scholar
• Abdel-Rahman SM, Kearns GL. Single oral dose escalation pharmacokinetics of pleconaril (VP63843) capsules in adults. J of Clin Pharm. 1999;39:613–8.
   PubMed Web of Science ®Google Scholar
• Kearns GL, Abdel-Rahman SM, James LP, Blowey DL, Marshall JD, Wells TG, et al. Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution in children and adolescents. Antimicrobial Anents and Chemotherapy. 1999;43:634–8.
   PubMed Web of Science ®Google Scholar
• Ansevin CF. Treatment of ALS with pleconaril. Neurology. 2001;56:691–2.
   PubMedGoogle Scholar
• McKinlay MA. Recent advances in the treatment of rhinovirus infections. Current Opinion Pharmacol. 2001;1:477–81.
   PubMedGoogle Scholar
• Okada I, Matsumori A, Matoba Y, Tominaga M, Yamada T, Kawai C. Combination treatment with ribavirin and interferon for coxsackievirus B3 replication. J Lab Clin Med. 1992;120:569–73.
   Google Scholar
• Waldmeier PC. Prospects for antiapoptotic drug thereapy of neurodegenerative diseases. Progress in Neuro- Psychopharmacology & Biological Psychiatry. j2003;27:303–21.
   Google Scholar
• Jacobson MD. Anti-apoptosis therapy: a way of treating neural degeneration? Curr Biol. 1998;8:R418–21.
   Google Scholar
• Tatton WG, Chalmers-Redman RM, Ju WY, Wadia J, Tatton NA. Apoptosis in neural degenerative disorders: potential for therapy by modifying gene transcription. J Neural Transm. 1997;49(Suppl): 245–68.
   Google Scholar
• Schulz JB, Weller M, Moskowitz MA. Caspases as treatment targets in stroke and neurodegenerative diseases. Ann Neurol. 1999;45:421–9.
   PubMed Web of Science ®Google Scholar
• Nicholson DW. From bench to clinic with apoptosis-based therapeutic agents. Nature. 2000;407:810–6.
   PubMed Web of Science ®Google Scholar
• Vandepapelie`r P. Thereapeutic vaccination against chronic viral infections. Lancet Infectious Diseases. 2002;2:353–67.
   Google Scholar
• Rotbart HA. Nucleic acid detection systems for entero- viruses. Clin Microbiol Rev. 1991;4:156–68.
   PubMedGoogle Scholar
• Romero JR, Rotbart HA. PCR-based strategies for the detection of human enteroviruses. In: Ehrlich GD, Greenberg SJ, editors. PCR-Based Diagnostics in Infectious Disease. Cambridge, MA: Blackwell Scientific Publications; 1994. p 341.
   Google Scholar
• Romero JR. Reverse transcription-polymerase chain reaction detection of the enteroviruses: overview and clinical utility in pediatric enteroviral infections. Archives of Pathology and Laboratory Medicine. 1999;123:1161–9.
   PubMed Web of Science ®Google Scholar
• Olive DM, Al-Mufti S, Al-Mulla W, Khan MA, Pasca A, Stanway G, Al-Nakib W. Detection and differentiation of picornaviruses in clinical samples following genomic ampli- fication. J Gen Virol. 1990;71:2141–7.
   PubMed Web of Science ®Google Scholar
• Gruber AD, Moennig V, Hewicker-Trautwein M, Trautwein G. Effect of formalin fixation and long-term storage on the detectability of bovine viral-diarrhoea-virus (BVDV) RNA in archival brain tissue using polymerase chain reaction. J Vet Med. 1994;41:654–61.
   Google Scholar
• Karlsen F, Kalantari M, Chitemerere M, Johansson B, Hagmar B. Modifications of human and viral deoxyribo- nucleic acid by formaldehyde fixation. Lab Investigation. 1994;71:604–11.
   PubMed Web of Science ®Google Scholar
• Jubelt B, Lipton HL. ALS: persistent scientists do not find persisting enteroviruses (editorial). Neurology. 2004;62:1250–1.
   Google Scholar
• Redline RW, Genest DR, Tycko B. Detection of enteroviral infection in paraffin-embedded tissue by the RNA polymer- ase chain reaction technique. Am J Clin Pathol. 1991;96:568–571.
   Google Scholar
• Rupp GM, Locker J. Purification and analysis of RNA from paraffin-embedded tissues. BioTechniques. 1988;6:56–60.
   PubMed Web of Science ®Google Scholar
• Ben-Ezra J, Johnson DA, Rossi J, Cook N, Wu A. Effect of fixation on the amplification of nucleic acids from paraffin- embedded material by the polymerase chain reaction. J Histochem Cytochem. 1991;39:351–4.
   PubMed Web of Science ®Google Scholar
• Foss RD, Guha-Thakurta N, Conran RM, Gutman P. Effects of fixative and fixation time on the extraction and polymerase chain reaction amplification of RNA from paraffin-embedded tissue. Comparison of two housekeeping gene mRNA controls. Diagnostic Mol Pathol. 1994;3:148–55.
   PubMedGoogle Scholar
• Dakhama A, Macek V, Hogg JC, Hegele RG. Amplifica- tion of human ß-actin gene by the reverse transciptase- polymerase chain reaction: implications for assessment of RNA from formalin-fixed, paraffin-embedded material. J Histochem Cytochem. 1996;44:1205–7.
   Google Scholar
• Coombs NJ, Gough AC, Primrose JN. Optimization of DNA and RNA extraction from archival formalin- fixed tissue. Nucleic Acids Research. 1999;27:1–3.
   Google Scholar
• Masuda N, Ohnishi T, Kawamoto S, Monden M, Okubo K. Analysis of chemical modification of RNA from formalin- fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Research. 1999;27:4436–43.
   PubMed Web of Science ®Google Scholar
• Beaulieux F, Berger MM, Tcheng R, Giraud P, Lina B. RNA extaction and RT-PCR procedures adapted for the detection of enterovirus sequences from fozen and paraffin- embedded formalin-fixed spinal cord samples. J Virol Methods. 2003;107:115–20.
   Google Scholar
• Wolk D, Mitchell S, Patel R. Principles of molecular microbiology testing methods. Infectious Disease Clinics of North America. 2001;15:1157–1204.
   PubMed Web of Science ®Google Scholar
• Reiss RA, Rutz B. Quality control PCR: a method for detecting inhibitors of Taq DNA polymerase. BioTechniques. 1999;27:920–6.
   PubMed Web of Science ®Google Scholar
• Konet DS, Mezencio JMS, Babcock G, et al. Inhibitors of RT-PCR in serum. J Virol Methods. 2000;84:95–8.
   Google Scholar
• Simone NL, Bonner RF, Gillespie JW, Emmert-Buck MR, Liotta LA. Laser-capture microdissection: opening the microscopic frontier to molecular analysis. Trends Genet. 1998;14:272–6.
   PubMed Web of Science ®Google Scholar
• Eltoum IA, Siegal GP, Frost AR. Microdissection of histologic sections: past, present, and future. Adv Anat Path. 2002;9:316–22.
   PubMed Web of Science ®Google Scholar